| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/11/1991 | CA2020786A1 Treatment of obesity and essential hypertension and related disorders |
| 01/10/1991 | WO1991000352A1 Pestivirus nucleotide sequences and polypeptides |
| 01/10/1991 | WO1991000351A1 Fungal stress proteins |
| 01/10/1991 | WO1991000349A1 Cytokine synthesis inhibitory factor, antagonists thereof, and methods of using same |
| 01/10/1991 | WO1991000348A1 Modified vp1/p2a regions of the rhinoviral system |
| 01/10/1991 | WO1991000340A1 Antibody to p. falciparum antigen and hybridoma for making same |
| 01/10/1991 | WO1991000295A1 Novel antibodies reactive with human carcinomas |
| 01/10/1991 | WO1991000292A1 Compositions and methods for the synthesis of natriuretic protein receptor b and methods of use |
| 01/10/1991 | WO1991000289A2 Targeted liposomes and methods for liposome-protein coupling |
| 01/10/1991 | WO1991000285A1 Tri-aza macrocycles and processes for their preparation |
| 01/10/1991 | WO1991000107A1 Vaccines and vectors with liquid active principles containing an oil which can be metabolised |
| 01/10/1991 | WO1991000106A1 Injectable multi-phase emulsions |
| 01/10/1991 | WO1990014427A3 Multivalent repressor of gene function |
| 01/10/1991 | WO1990012807A3 Purified, highly specific antibodies against gene products including retinoblastoma and method |
| 01/10/1991 | DE3922444A1 Virus modified tumour specific vaccine - contains immunostimulating substances, and is used in immuno-therapy of tumours |
| 01/10/1991 | CA2059131A1 Compositions and methods for the synthesis of natriuretic protein receptor b and methods of use |
| 01/09/1991 | EP0407230A1 Sporozoite and liver-stage protein antigen of P. falciparum |
| 01/09/1991 | EP0407037A1 Process for removing bacterial endotoxin from gram-negative polysaccharides |
| 01/09/1991 | EP0406880A2 Method for stimulating macrophage activity against tumors and composition therefor |
| 01/09/1991 | EP0406857A1 Proteins and production thereof |
| 01/09/1991 | EP0406804A2 Modified biologically active protein |
| 01/09/1991 | EP0406557A2 Multivalent repressor of gene function |
| 01/09/1991 | EP0406511A1 Cloning of non A non B hepatitis virus gene and expression thereof |
| 01/09/1991 | EP0406367A1 Scavenger receptor protein and antibody thereto |
| 01/09/1991 | EP0406317A1 Method and means for immuno-stimulating blood treatment with mitogen |
| 01/09/1991 | EP0406286A1 Dna encoding a ryegrass pollen allergen |
| 01/09/1991 | EP0406259A1 Antibodies, process for producing them, clones for the production of the antibodies, and use of the antibodies for diagnosis and therapy of tumours. |
| 01/09/1991 | EP0406257A1 Proteins which induce immunological effector cell activation and chemattraction |
| 01/09/1991 | EP0197062B1 Anti-leishmania monoclonal antibodies, hybridomas secreting said antibodies, antigens of leishmania recognized by said antibodies, method for obtaining them and applications of said monoclonal antibodies and said antigens |
| 01/09/1991 | CN1048328A Srif-related peptides and uses thereof |
| 01/08/1991 | WO1991000740A1 Vaccine for immunizing cats against toxoplasma oocyst shedding |
| 01/08/1991 | WO1990010058A2 Method for production and purification of hepatitis b vaccine |
| 01/08/1991 | US4983722 Exposure to anion exchange material, adsorption, elution |
| 01/08/1991 | US4983598 Pharmaceutical composition containing diltiazem and angiotensin-converting enzyme inhibitor |
| 01/08/1991 | US4983520 DNA sequence encoding modified hepatitis B virus surface antigen P31 protein |
| 01/08/1991 | US4983387 Antibody producing polypeptide |
| 01/08/1991 | CA2063438A1 Vaccine for immunizing cats against toxoplasma oocyst shedding |
| 01/08/1991 | CA2020593A1 Method for stimulating macrophage activity against tumors and composition therefor |
| 01/06/1991 | CA2020543A1 Monoclonal antibodies directed against activated microglia cells, hybridomas secreting these monoclonal antibodies, antigen recognized by these monoclonal antibodies and their applications |
| 01/06/1991 | CA2020303A1 Cytokines |
| 01/02/1991 | EP0406175A2 Muramyl dipeptide derivatives |
| 01/02/1991 | EP0406029A1 Fungal stress proteins |
| 01/02/1991 | EP0405980A1 Cytokine synthesis inhibitory factor, antagonists thereof, and methods of using same |
| 01/02/1991 | EP0405867A1 Novel compounds |
| 01/02/1991 | EP0405763A1 GRF peptides |
| 01/02/1991 | EP0404912A1 Monoclonal antibodies reactive with defined regions of the t cell antigen receptor |
| 01/02/1991 | CA1278514C Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process |
| 01/02/1991 | CA1278513C Canine parvovirus vaccines |
| 01/01/1991 | US4981979 Immunoconjugates joined by thioether bonds having reduced toxicity and improved selectivity |
| 01/01/1991 | US4981961 Chemically-stable chromatography adsorber; modifying nucleophilic polymers with pyridine bases |
| 01/01/1991 | US4981953 Antitumor |
| 01/01/1991 | US4981782 Synthetic peptides for diagnosis and prevention of influenza virus infection and their use |
| 01/01/1991 | US4981685 Glycopyranoside detergent |
| 01/01/1991 | US4981684 Formation of adjuvant complexes |
| 12/30/1990 | WO1991000293A1 Vasodilatory and immune suppressant peptides |
| 12/30/1990 | WO1991000104A1 Production of virus and purification of viral envelope proteins for vaccine use |
| 12/30/1990 | CA2063260A1 Vasodilatory and immune suppressant peptides |
| 12/29/1990 | CA2019922A1 Muramyl dipeptide derivatives |
| 12/27/1990 | WO1990015873A1 Vector-mediated genomic insertion and expression of dna in bcg |
| 12/27/1990 | WO1990015871A1 Expression of tetanus toxin fragment c |
| 12/27/1990 | WO1990015627A1 Methods and compositions for the preparation and use of site-directed immunologic reagents |
| 12/27/1990 | WO1990015626A1 Methods for technetium/rhenium labelling of proteins |
| 12/27/1990 | WO1990015624A1 Contraceptive vaccine based on cloned zona pellucida gene |
| 12/27/1990 | WO1990015623A1 Naturally attenuated newcastle disease vaccine and method of using the same |
| 12/27/1990 | WO1990015621A1 A malaria vaccine |
| 12/27/1990 | WO1990015614A1 ANTIGENIC EPITOPES PRESENT ON MEMBRANE-BOUND BUT NOT SECRETED IgA |
| 12/27/1990 | WO1990013314A3 Antigenes of the envelope transmembrane glycoprotein of a human retrovirus of the hiv-2 type, and antigens presenting with them an immunological relationship |
| 12/27/1990 | EP0404625A2 Oligonucleotide sequences for amplification of type HIV-2 and SIV retroviruses genomes and their application to in-vitro diagnostic of infections caused by these viruses |
| 12/27/1990 | EP0404605A2 Tri-aza macrocycles and processes for their production |
| 12/27/1990 | EP0404576A2 Recombinant avipoxvirus |
| 12/27/1990 | EP0404186A2 Process of measuring specific antibody |
| 12/27/1990 | EP0404097A2 Bispecific and oligospecific, mono- and oligovalent receptors, production and applications thereof |
| 12/27/1990 | EP0403961A2 Magnetic protein conjugates, process to make them and their use |
| 12/27/1990 | EP0403960A2 Magnetic protein conjugates, method to make them and their use |
| 12/27/1990 | EP0403698A1 Eimeria tenella vaccine |
| 12/27/1990 | EP0403559A1 Improvements relating to antigens |
| 12/27/1990 | EP0403541A1 Immunogenic glycoproteins of human cytomegalovirus |
| 12/27/1990 | EP0403524A1 Preparation of nitruro compounds usable as radio-pharmaceutical products. |
| 12/27/1990 | EP0214995B1 Immunotoxin and method of making |
| 12/27/1990 | EP0120958B1 Characterization of oncogenes and assays based thereon |
| 12/27/1990 | CA2063414A1 Vector-mediated genomic insertion and expression of dna in bcg |
| 12/27/1990 | CA2058999A1 Contraceptive vaccine based on cloned zona pellucida gene |
| 12/27/1990 | CA2019845A1 Compounds |
| 12/25/1990 | US4980462 Antiviral agents |
| 12/25/1990 | US4980457 Coupling of ricin and antibody |
| 12/25/1990 | US4980162 Live vaccine for contagious diseases of chickens |
| 12/25/1990 | CA2019661A1 Modified vp1/p2a region of the rhinovirus system |
| 12/24/1990 | WO1991000105A1 Vaccine against bovine leukemia virus |
| 12/24/1990 | CA2033071A1 Bovine leukemia virus vaccine |
| 12/23/1990 | WO1990015618A2 Srif-related peptides and uses thereof |
| 12/23/1990 | CA2059280A1 Srif-related peptides and uses thereof |
| 12/22/1990 | WO1990015872A1 Recombinant poxvirus and streptococcal m protein vaccine |
| 12/22/1990 | CA2019215A1 Recombinant avipoxvirus |
| 12/20/1990 | WO1990015625A1 RADIOIMMUNOTHERAPY USING α-PARTICLES EMISSION |
| 12/19/1990 | EP0403333A2 Nucleotide sequences of retroviral genomes of types HIV-I, HIV-2 and SIV, their uses for the amplification of these genomes and diagnosis in vitro of these viral infections |
| 12/19/1990 | EP0403312A1 Immunoactive peptides and antibodies and their use in anti-allergy treatment |
| 12/19/1990 | EP0403225A2 Methods for technetium/rhenium labelling of proteins |
| 12/19/1990 | EP0403156A1 Improved monoclonal antibodies against the human alpha/beta t-cell receptor, their production and use |
| 12/19/1990 | EP0403114A1 Interleukin-7 receptors |
| 12/19/1990 | EP0402418A1 Physiological active liquid allergenic composition from biological raw materials |